<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:spacs="http://spacs/20260331"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="spacs-20260331.xsd" xlink:type="simple"/>
    <context id="From2026-01-01to2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_UnitsEachConsistingOfOneClassOrdinaryShareOnehalfOfOneRedeemableWarrantandOneRightToReceiveOnefifthOfOneClassOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:UnitsEachConsistingOfOneClassOrdinaryShareOnehalfOfOneRedeemableWarrantandOneRightToReceiveOnefifthOfOneClassOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_ClassOrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassOrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareatExercisePriceOf11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareatExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifth15OfOneClassOrdinaryShareuponConsummationOfInitialBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:RightsEachRightEntitlingHolderToReceiveOnefifth15OfOneClassOrdinaryShareuponConsummationOfInitialBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-15_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-15</instant>
        </period>
    </context>
    <context id="AsOf2026-05-15_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-15</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassAOrdinarySharesMember139616937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">spacs:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassBOrdinarySharesMember139616937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">spacs:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ClassAOrdinarySharesMember139616953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">spacs:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ClassBOrdinarySharesMember139616953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">spacs:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-09_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-09</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">spacs:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">spacs:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-06-012025-06-28_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">spacs:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-28_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">spacs:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-28</instant>
        </period>
    </context>
    <context id="From2025-06-012025-06-28_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">spacs:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-28</endDate>
        </period>
    </context>
    <context id="From2025-06-012025-06-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-28</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_FounderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">spacs:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <instant>2025-06-28</instant>
        </period>
    </context>
    <context id="AsOf2026-01-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">spacs:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_ManagingSponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">spacs:ManagingSponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">spacs:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="From2025-06-012025-06-28_custom_FounderSharesMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">spacs:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-28</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_custom_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">spacs:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">spacs:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-02-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
        </entity>
        <period>
            <instant>2026-02-09</instant>
        </period>
    </context>
    <context id="AsOf2026-02-09_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">spacs:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-09</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">spacs:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-09_custom_PublicRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">spacs:PublicRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-09</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_custom_PublicRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">spacs:PublicRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-09_custom_RestrictedSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">spacs:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-09</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-09_custom_RestrictedSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002081300</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">spacs:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2026-01-01to2026-03-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2026-01-01to2026-03-31" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2026-01-01to2026-03-31" id="Fact000005">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2026-01-01to2026-03-31" id="Fact000006">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2026-01-01to2026-03-31" id="Fact000007">0002081300</dei:EntityCentralIndexKey>
    <spacs:DueFromSponsor
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0059"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0062"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0065"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentsAndCash
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0074"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:PromissoryNoteRelatedParty
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0091"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:DeferredUnderwritingFeePayable
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0098"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0107"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0120"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0157"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0225"
      unitRef="Shares"
      xsi:nil="true"/>
    <spacs:AccretionForClassOrdinarySharesToRedemptionAmount
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0229"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:AccretionForClassOrdinarySharesToRedemptionAmount
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0236"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:FairValueOfPublicWarrantsAtIssuance
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:FairValueOfPublicWarrantsAtIssuance
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:FairValueOfPublicWarrantsAtIssuance
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:FairValueOfRightsIncludedInPublicUnits
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:FairValueOfRightsIncludedInPublicUnits
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0262"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:FairValueOfRightsIncludedInPublicUnits
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:AllocatedValueOfTransactionCostsToClassShares
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:AllocatedValueOfTransactionCostsToClassShares
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <spacs:AllocatedValueOfTransactionCostsToClassShares
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember139616937"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2025-12-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrust
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0782"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2026-01-01to2026-03-31" id="Fact000013">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2026-01-01to2026-03-31" id="Fact000014">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2026-01-01to2026-03-31" id="Fact000015">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2026-01-01to2026-03-31" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2026-01-01to2026-03-31" id="Fact000017">001-43093</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2026-01-01to2026-03-31" id="Fact000018">SPACSPHERE ACQUISITION CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2026-01-01to2026-03-31" id="Fact000019">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2026-01-01to2026-03-31" id="Fact000020">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2026-01-01to2026-03-31" id="Fact000021">8795 Folsom Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2026-01-01to2026-03-31" id="Fact000022">Sacramento</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2026-01-01to2026-03-31" id="Fact000023">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2026-01-01to2026-03-31" id="Fact000024">95826</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2026-01-01to2026-03-31" id="Fact000025">(501)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2026-01-01to2026-03-31" id="Fact000026">201-0130</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-03-31_custom_UnitsEachConsistingOfOneClassOrdinaryShareOnehalfOfOneRedeemableWarrantandOneRightToReceiveOnefifthOfOneClassOrdinaryShareMember"
      id="Fact000027">Units, each consisting of one Class A Ordinary Shares, one-half of one redeemable warrant,&#160;and one right to receive one-fifth</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-03-31_custom_UnitsEachConsistingOfOneClassOrdinaryShareOnehalfOfOneRedeemableWarrantandOneRightToReceiveOnefifthOfOneClassOrdinaryShareMember"
      id="Fact000028">SSACU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-03-31_custom_UnitsEachConsistingOfOneClassOrdinaryShareOnehalfOfOneRedeemableWarrantandOneRightToReceiveOnefifthOfOneClassOrdinaryShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-03-31_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000030">Class A Ordinary Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-03-31_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000031">SSAC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-03-31_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareatExercisePriceOf11.50PerShareMember"
      id="Fact000033">Redeemable warrants, each whole warrant exercisable for one Class A ordinary share&#160;at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareatExercisePriceOf11.50PerShareMember"
      id="Fact000034">SSACW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-03-31_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareatExercisePriceOf11.50PerShareMember"
      id="Fact000035">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-03-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifth15OfOneClassOrdinaryShareuponConsummationOfInitialBusinessCombinationMember"
      id="Fact000036">Rights, each right entitling the holder to receive one-fifth (1/5) of one Class A ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-03-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifth15OfOneClassOrdinaryShareuponConsummationOfInitialBusinessCombinationMember"
      id="Fact000037">SSACR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-03-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifth15OfOneClassOrdinaryShareuponConsummationOfInitialBusinessCombinationMember"
      id="Fact000038">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2026-01-01to2026-03-31" id="Fact000039">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2026-01-01to2026-03-31" id="Fact000040">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2026-01-01to2026-03-31" id="Fact000041">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2026-01-01to2026-03-31" id="Fact000042">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2026-01-01to2026-03-31" id="Fact000043">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2026-01-01to2026-03-31" id="Fact000044">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="From2026-01-01to2026-03-31" id="Fact000045">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-05-15_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000046"
      unitRef="Shares">18297994</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-05-15_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000047"
      unitRef="Shares">5750000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000055"
      unitRef="USD">308000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">6081</us-gaap:CashEquivalentsAtCarryingValue>
    <spacs:DueFromSponsor
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000058"
      unitRef="USD">192493</spacs:DueFromSponsor>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000061"
      unitRef="USD">51429</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000064"
      unitRef="USD">120223</us-gaap:PrepaidInsurance>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">672145</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">6081</us-gaap:AssetsCurrent>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">587984</us-gaap:DeferredOfferingCosts>
    <us-gaap:InvestmentsAndCash
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000073"
      unitRef="USD">173360706</us-gaap:InvestmentsAndCash>
    <us-gaap:Assets
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000076"
      unitRef="USD">174032851</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">594065</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000085"
      unitRef="USD">172445</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">60417</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000088"
      unitRef="USD">208270</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000089"
      unitRef="USD">401313</us-gaap:AccruedMarketingCostsCurrent>
    <spacs:PromissoryNoteRelatedParty
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">217513</spacs:PromissoryNoteRelatedParty>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000094"
      unitRef="USD">380715</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">679243</us-gaap:LiabilitiesCurrent>
    <spacs:DeferredUnderwritingFeePayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000097"
      unitRef="USD">12075000</spacs:DeferredUnderwritingFeePayable>
    <us-gaap:Liabilities
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000100"
      unitRef="USD">12455715</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000101"
      unitRef="USD">679243</us-gaap:Liabilities>
    <spacs:OrdinaryShares.SubjectToPossibleRedemption
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000109"
      unitRef="Shares">17250000</spacs:OrdinaryShares.SubjectToPossibleRedemption>
    <spacs:OrdinaryShares.SubjectToPossibleRedemption
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000111"
      unitRef="Shares">0</spacs:OrdinaryShares.SubjectToPossibleRedemption>
    <spacs:OrdinarySharesParShares
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000113"
      unitRef="USDPShares">10.05</spacs:OrdinarySharesParShares>
    <spacs:OrdinarySharesParShares
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000115"
      unitRef="USDPShares">0</spacs:OrdinarySharesParShares>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000106"
      unitRef="USD">173360706</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000123"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000125"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000127"
      unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000129"
      unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000131"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000133"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000135"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000137"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000139"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000141"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000143"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000145"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000147"
      unitRef="Shares">1047994</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000149"
      unitRef="Shares">1047994</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000151"
      unitRef="Shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000153"
      unitRef="Shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000155"
      unitRef="USD">105</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000159"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000161"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000163"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000165"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000167"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000169"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000171"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000173"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="0"
      id="Fact000175"
      unitRef="USD">575</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="0"
      id="Fact000177"
      unitRef="USD">575</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000180"
      unitRef="USD">24425</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000182"
      unitRef="USD">-11784250</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000183"
      unitRef="USD">-110178</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000185"
      unitRef="USD">-11783570</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000186"
      unitRef="USD">-85178</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000188"
      unitRef="USD">174032851</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000189"
      unitRef="USD">594065</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000192"
      unitRef="USD">212358</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000194"
      unitRef="USD">-212358</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000198"
      unitRef="USD">860706</us-gaap:InterestAndOtherIncome>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000200"
      unitRef="USD">648348</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000202"
      unitRef="Shares">10165552</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000204"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000206"
      unitRef="Shares">10165552</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000208"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000210"
      unitRef="Shares">5416667</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000212"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000216"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember139616937"
      decimals="INF"
      id="Fact000227"
      unitRef="Shares">5750000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember139616937"
      decimals="0"
      id="Fact000220"
      unitRef="USD">575</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000221"
      unitRef="USD">24425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000222"
      unitRef="USD">-110178</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000223"
      unitRef="USD">-85178</us-gaap:StockholdersEquity>
    <spacs:AccretionForClassOrdinarySharesToRedemptionAmount
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000231"
      unitRef="USD">-7733416</spacs:AccretionForClassOrdinarySharesToRedemptionAmount>
    <spacs:AccretionForClassOrdinarySharesToRedemptionAmount
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000232"
      unitRef="USD">-12322420</spacs:AccretionForClassOrdinarySharesToRedemptionAmount>
    <spacs:AccretionForClassOrdinarySharesToRedemptionAmount
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000233"
      unitRef="USD">-20055836</spacs:AccretionForClassOrdinarySharesToRedemptionAmount>
    <spacs:SaleOfPrivatePlacementShares
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000241"
      unitRef="Shares">279465</spacs:SaleOfPrivatePlacementShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      decimals="INF"
      id="Fact000243"
      unitRef="Shares">279465</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      decimals="0"
      id="Fact000235"
      unitRef="USD">28</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000237"
      unitRef="USD">1813210</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000239"
      unitRef="USD">1813238</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <spacs:SaleOfPrivatePlacementShare
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000251"
      unitRef="Shares">768529</spacs:SaleOfPrivatePlacementShare>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      decimals="INF"
      id="Fact000253"
      unitRef="Shares">768529</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember139616937"
      decimals="0"
      id="Fact000245"
      unitRef="USD">77</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000247"
      unitRef="USD">981335</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000249"
      unitRef="USD">981412</us-gaap:StockIssuedDuringPeriodValueOther>
    <spacs:FairValueOfPublicWarrantsAtIssuance
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000257"
      unitRef="USD">974625</spacs:FairValueOfPublicWarrantsAtIssuance>
    <spacs:FairValueOfPublicWarrantsAtIssuance
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000259"
      unitRef="USD">974625</spacs:FairValueOfPublicWarrantsAtIssuance>
    <spacs:FairValueOfRightsIncludedInPublicUnits
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000263"
      unitRef="USD">4398750</spacs:FairValueOfRightsIncludedInPublicUnits>
    <spacs:FairValueOfRightsIncludedInPublicUnits
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000265"
      unitRef="USD">4398750</spacs:FairValueOfRightsIncludedInPublicUnits>
    <spacs:AllocatedValueOfTransactionCostsToClassShares
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000269"
      unitRef="USD">-458929</spacs:AllocatedValueOfTransactionCostsToClassShares>
    <spacs:AllocatedValueOfTransactionCostsToClassShares
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000271"
      unitRef="USD">-458929</spacs:AllocatedValueOfTransactionCostsToClassShares>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">648348</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000277"
      unitRef="USD">648348</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember139616953"
      decimals="INF"
      id="Fact000285"
      unitRef="Shares">1047994</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_custom_ClassAOrdinarySharesMember139616953"
      decimals="0"
      id="Fact000279"
      unitRef="USD">105</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember139616953"
      decimals="INF"
      id="Fact000287"
      unitRef="Shares">5750000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_custom_ClassBOrdinarySharesMember139616953"
      decimals="0"
      id="Fact000280"
      unitRef="USD">575</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000282"
      unitRef="USD">-11784250</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000283"
      unitRef="USD">-11783570</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000291"
      unitRef="USD">648348</us-gaap:NetIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000295"
      unitRef="USD">860706</us-gaap:InterestAndOtherIncome>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000299"
      unitRef="USD">171652</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000301"
      unitRef="USD">112028</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000303"
      unitRef="USD">-271982</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <spacs:InvestmentOfCashInTrustAccount
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000307"
      unitRef="USD">172500000</spacs:InvestmentOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000309"
      unitRef="USD">-172500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <spacs:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000313"
      unitRef="USD">169050000</spacs:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">2794650</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <spacs:UnderwritersReimbursement
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000317"
      unitRef="USD">2156250</spacs:UnderwritersReimbursement>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000319"
      unitRef="USD">410006</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000321"
      unitRef="USD">516993</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000323"
      unitRef="USD">173073901</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000325"
      unitRef="USD">301919</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000327"
      unitRef="USD">6081</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000329"
      unitRef="USD">308000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <spacs:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000333"
      unitRef="USD">208270</spacs:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
    <spacs:DeferredUnderwritingFeesPayable
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000335"
      unitRef="USD">12075000</spacs:DeferredUnderwritingFeesPayable>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000337">&lt;p id="xdx_800_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z3tqPnx0TPpd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 1 &#x2014; &lt;span id="xdx_824_zsdslamGoK48"&gt;Description of Organization and Business Operations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;SPACSphere Acquisition Corp. (the &#x201c;Company&#x201d; or &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) was incorporated in the Cayman Islands on June&#160;18, 2025. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination (the &#x201c;Business Combination&#x201d;). The Company has not selected any specific Business Combination target. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;As of March&#160;31, 2026, the Company had not commenced any operations. All activity for the period from June&#160;18, 2025 (inception) through March&#160;31, 2026, relates to the Company&#x2019;s formation, the initial public offering described below (the &#x201c;Initial Public Offering&#x201d;), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s sponsor is SPACSphere Sponsor LLC, a Delaware limited liability company (the &#x201c;Sponsor&#x201d;). On February&#160;9, 2026, the Company consummated its Initial Public Offering of &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTjnuXqEhyBc" title="Sale of units in public offering"&gt;17,250,000&lt;/span&gt; units (the &#x201c;Units&#x201d;), including the purchase by the underwriters of &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zY3jolpn01yg" title="Sale of units in public offering"&gt;2,250,000&lt;/span&gt; additional Units at the offering price, reflecting the exercise of their option to purchase additional Units to cover over-allotments. The Units were sold at a price of $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHylycyS4zJe" title="Sale of units per share"&gt;10.00&lt;/span&gt;, per Unit, generating gross proceeds to the Company of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFz01qqubb7f" title="Proceeds from issuance initial public offering"&gt;172,500,000&lt;/span&gt; which is discussed in Note 3. Each public Unit consists of one Class A ordinary share (each a &#x201c;Class A Ordinary Share&#x201d; and collectively, the &#x201c;Public Shares&#x201d;), one-half of one redeemable warrant, and one right to receive one-fifth (1/5) of one Class A ordinary share upon the consummation of the initial Business Combination (the &#x201c;Share Rights&#x201d;).&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Simultaneously with consummation of the Initial Public Offering, the Company consummated the sale of (a) &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzXlKrahKQj3" title="Sale of units in public offering"&gt;279,465&lt;/span&gt; private placement units (each, a &#x201c;Private Placement Unit&#x201d; and collectively, the &#x201c;Private Placement Units&#x201d;) and (b) &lt;span id="xdx_904_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlwDvvxzAw68" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;768,529&lt;/span&gt; restricted Class A Ordinary Shares, which shares shall be subject to (i) certain restrictions which only lapse upon the consummation of the initial Business Combination and (ii) surrender for nil consideration if an initial Business Combination is not consummated in accordance with the amended and restated memorandum and articles of association (each, a &#x201c;Restricted Class A Ordinary Share&#x201d; and the Restricted Class A Ordinary Shares collectively with the Private Placement Units, the &#x201c;Private Placement Securities&#x201d;) to our Sponsor and certain private placement investors, generating gross proceeds of $2,794,650. The Private Placement Units are identical to the Units, except that the Private Placement Units (and the underlying securities) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days following the consummation of the Company&#x2019;s initial Business Combination. The Restricted Class A Ordinary Shares are Class A Ordinary Shares of the Company that have had certain voting and transfer rights contractually waived until 30 days following the consummation of the Company&#x2019;s initial Business Combination.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Transaction costs amounted to $&lt;span id="xdx_906_ecustom--TransactionCosts_pp0p0_c20260101__20260331_ziWN5nLFtzoj" title="Transaction costs"&gt;14,280,684&lt;/span&gt;, consisting of $&lt;span id="xdx_903_ecustom--CashUnderwriting_pp0p0_c20260101__20260331_zOKCCLTi93L3" title="Cash underwriting"&gt;1,293,750&lt;/span&gt; of cash underwriting fee (net of $&lt;span id="xdx_90F_ecustom--UnderwritersReimbursement_pp0p0_c20260101__20260331_zg2My4VVoUCl" title="Underwriters reimbursement"&gt;2,156,250&lt;/span&gt; underwriters&#x2019; reimbursement), $&lt;span id="xdx_906_eus-gaap--OtherUnderwritingExpense_pp0p0_c20260101__20260331_zq0fAv7zb15j" title="Deferred underwriting fees"&gt;12,075,000&lt;/span&gt; of deferred underwriting fee, and $&lt;span id="xdx_903_ecustom--OtherOfferingCosts_iI_pp0p0_c20260331_z7tfgSbKjk03" title="Other offering costs"&gt;911,934&lt;/span&gt; of other offering costs.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0px; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s Business Combination must be with one or more target businesses that together have a fair market value equal to at least &lt;span id="xdx_903_ecustom--PercentageOfAssetHeldInTrustAccount_dp_c20260101__20260331_zughzAYYrPY" title="Percentage of asset held in trust account"&gt;80&lt;/span&gt;% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and any Permitted Withdrawals) at the time of  signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires &lt;span id="xdx_90E_ecustom--BusinessCombinationPercentageOfVotingSecurities_iI_dp_c20260331_zSeh7rNyzme3" title="Business combination, percentage of voting securities"&gt;50&lt;/span&gt;% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Following the closing of the Initial Public Offering, on February&#160;9, 2026, an amount of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBuVeXIhxsVi" title="Proceeds from issuance initial public offering"&gt;172,500,000&lt;/span&gt; ($&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzcXVbEXbbc3" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement was placed in the trust account (the &#x201c;Trust Account&#x201d;) and invested or held in either (i) U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, (ii) uninvested cash, or (iii) an interest-bearing bank demand deposit account or other accounts at a bank, as determined by the Company, until the earlier of (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company&#x2019;s shareholders, as described below.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will provide the holders of the outstanding Public Shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares (as defined in Note 3) for a pro rata portion of the amount then in the Trust Account, subject to the limitations described in the prospectus (initially anticipated to be $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of Permitted Withdrawals). There will be no redemption rights with respect to the Company&#x2019;s warrants and Share Rights.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;All
of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the
Company&#x2019;s liquidation, if there is a shareholder vote or tender offer in connection with the Company&#x2019;s Business
Combination and in connection with certain amendments to the Company&#x2019;s amended and restated memorandum and articles of
association. In accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;) Subtopic 10-S99,
redemption provisions not solely within the control of a company require Class A Ordinary Shares subject to redemption to be
classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., warrants
and Public Share Rights (as defined in Note 3)), the initial carrying value of the Public Shares classified as temporary equity are the allocated proceeds
determined in accordance with ASC 470-20, &#x201c;Debt with Conversion and other Options&#x201d;. The Public Shares are subject to ASC
480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete
changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the
instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the
redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end
of each reporting period. The Company has elected to recognize the changes immediately. The Public Shares are redeemable and are
classified as such on the condensed balance sheets until such date that a redemption event takes place.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Redemptions
of the Company&#x2019;s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant
to an agreement relating to the Company&#x2019;s Business Combination. If the Company seeks shareholder approval of the Business
Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the
Business Combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by
applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or
other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the
redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) and file tender
offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is
required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for
business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy
rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business
Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 4) and any Public Shares purchased during or
after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to
redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed
transaction.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Notwithstanding the foregoing, the amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to an aggregate of 15% or more of the Class A Ordinary Shares sold in the Initial Public Offering, without the prior consent of the Company.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s Sponsor, officers and directors (the &#x201c;initial shareholders&#x201d;) have agreed not to propose an amendment to the amended and restated memorandum and articles of association that would affect the substance or timing of the Company&#x2019;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public shareholders with the opportunity to redeem their Class A Ordinary Shares in conjunction with any such amendment.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;If the Company is unable to complete a Business Combination within 15 months from the closing of the Initial Public Offering or during any Extension Period (the &#x201c;Combination Period&#x201d;), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the per-share pro rata portion of the aggregate amount then on deposit in the Trust Account including interest earned thereon not previously released to the Company (such interest net of Permitted Withdrawals and less up to $&lt;span id="xdx_905_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20260331_zWNUuSTxvuO2" title="Interest payable"&gt;100,000&lt;/span&gt; of dissolution expenses), divided by the number of then outstanding Public Shares, subject to applicable law as further described in the prospectus, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining shareholders and the Company&#x2019;s board of directors, dissolve and liquidate, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within  the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares, subject to the limitations described herein. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Going Concern Consideration&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;As of March&#160;31, 2026, the Company had $&lt;span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_c20260331_zUL8rZa8UtP7" title="Cash equivalents"&gt;308,000&lt;/span&gt; in cash equivalents and $&lt;span id="xdx_907_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20260331_zLl7PSoKSFua" title="Working capital deficit"&gt;291,430&lt;/span&gt; in working capital.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $&lt;span id="xdx_905_ecustom--WorkingCapitalLoans_iI_c20260331_zXWLcHPE9Upf" title="Working capital loans"&gt;1,000,000&lt;/span&gt; of the Working Capital Loans may be converted upon completion of a Business Combination into private units at a price of $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zr9VbA3dXGv6" title="Sale of units per share"&gt;10.00&lt;/span&gt; per unit. Such private units would be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of March&#160;31, 2026, there were no Working Capital Loans outstanding.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The
Company has completed its Initial Public Offering at which time capital in excess of the funds deposited in Trust Account and/or
used to fund offering expenses was released to the Company for general capital purposes. Further, the Company has incurred and
expects to continue to incur significant costs in pursuit of its financing and acquisition plans. In connection with the
Company&#x2019;s assessment of going concern considerations in accordance with FASB ASC 205-40, &#x201c;Financial Statement
Presentation &#x2014; Going Concern,&#x201d; the Company&#x2019;s management has reevaluated the Company&#x2019;s liquidity and
financial condition, and determined that the Company still lacks the liquidity to sustain operations for a reasonable period of
time, which is considered to be one year from the date of the issuance of the unaudited condensed financial statements. These
conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. Management plans to address
this uncertainty with the Business Combination. There is no assurance that the Company&#x2019;s plans to complete the Business
Combination will be successful. No adjustments have been made to the carrying amounts of assets or liabilities should we be required
to liquidate after May&#160;9, 2027.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000339"
      unitRef="Shares">17250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000341"
      unitRef="Shares">2250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-09_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000343"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-02-012026-02-09_us-gaap_IPOMember"
      decimals="0"
      id="Fact000345"
      unitRef="USD">172500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000347"
      unitRef="Shares">279465</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000349"
      unitRef="Shares">768529</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <spacs:TransactionCosts
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000351"
      unitRef="USD">14280684</spacs:TransactionCosts>
    <spacs:CashUnderwriting
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000353"
      unitRef="USD">1293750</spacs:CashUnderwriting>
    <spacs:UnderwritersReimbursement
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000355"
      unitRef="USD">2156250</spacs:UnderwritersReimbursement>
    <us-gaap:OtherUnderwritingExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000357"
      unitRef="USD">12075000</us-gaap:OtherUnderwritingExpense>
    <spacs:OtherOfferingCosts
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000359"
      unitRef="USD">911934</spacs:OtherOfferingCosts>
    <spacs:PercentageOfAssetHeldInTrustAccount
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000367"
      unitRef="Ratio">0.80</spacs:PercentageOfAssetHeldInTrustAccount>
    <spacs:BusinessCombinationPercentageOfVotingSecurities
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000369"
      unitRef="Ratio">0.50</spacs:BusinessCombinationPercentageOfVotingSecurities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-02-012026-02-09_us-gaap_IPOMember"
      decimals="0"
      id="Fact000371"
      unitRef="USD">172500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-09_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000373"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000381"
      unitRef="USD">100000</us-gaap:InterestPayableCurrent>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000389"
      unitRef="USD">308000</us-gaap:CashEquivalentsAtCarryingValue>
    <spacs:WorkingCapitalDeficit
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000391"
      unitRef="USD">291430</spacs:WorkingCapitalDeficit>
    <spacs:WorkingCapitalLoans
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000393"
      unitRef="USD">1000000</spacs:WorkingCapitalLoans>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-03-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000395"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000403">&lt;p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zNfVHlIViHZc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 2 &#x2014; &lt;span id="xdx_82E_zgqvdGgHshV1"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVd4t4WVSBOd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_86C_z2JVHbwNJWsk"&gt;&lt;b&gt;&lt;i&gt;Basis
                                            of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the period ended December&#160;31, 2025, as filed with the SEC on March&#160;27, 2026, as well as the Company&#x2019;s Current Report on Form 8-K filed with the SEC on February&#160;17, 2026. The interim results for the three months ended March&#160;31, 2026, are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2026, or for any future periods.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zgRWBsUlk2Uf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zqNuaiScuSa7"&gt;Emerging Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Section&#160;102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_846_eus-gaap--UseOfEstimates_zmuYxuPctdkb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_ziwjI3goylxf"&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the unaudited condensed financial statements. Actual results could differ from those estimates.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zYCh8W0taGjf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_z4Y2Yeunx4E2"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash and $&lt;span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20260331_zGFprr6luF2c" title="Cash equivalents"&gt;308,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20251231_zn9nhE9WC7hd" title="Cash equivalents"&gt;6,081&lt;/span&gt; of cash equivalents as of March&#160;31, 2026 and December&#160;31, 2025, respectively.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p id="xdx_845_ecustom--CashAndMarketableSecuritiesHeldIinTrustAccountPolicyTextBlock_zdCeeeKCW3Af" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zWvzTKaHDAob"&gt;Cash and marketable securities held in Trust Account&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;As of March&#160;31, 2026, the assets held in the Trust Account, amounting to $&lt;span id="xdx_90B_eus-gaap--InvestmentsAndCash_iI_c20260331_zQZqiZHTEdHd" title="Cash and marketable securities held in Trust Account"&gt;173,360,706&lt;/span&gt;, were held in money cash and marketable securities held in Trust Account. As of December&#160;31, 2025, there were no assets held in the Trust Account. The investments held in money market funds are classified as trading securities. Gains and losses resulting from the change in fair value of these securities are included in interest earned on marketable securities held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zapHrkBYI3n4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zqa5hoXPj0g7"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $&lt;span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20260331_zQ5k7qV2KaU5" title="FDIC Coverage limit"&gt;250,000&lt;/span&gt;. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_846_ecustom--OfferingCostsPolicyTextBlock_zZDlKBrx9Tci" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zKn1YQgkzdp5"&gt;Offering Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A Ordinary Shares, warrants, and rights, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and rights and then to the Class A Ordinary Shares. Offering costs allocated to the Public Shares are charged to temporary equity, and offering costs allocated to the warrants and share rights in the Units, the Private Placement Units, and the Restricted Class A Ordinary Shares are charged to shareholders&#x2019; deficit, as the warrants and rights included in the Units and Private Placement Units, after management&#x2019;s evaluation, are accounted for under equity treatment.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9PqJibkBgmk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_z2XWPcBSgZs7"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the  condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_z8mpjpCnbgPf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zgBizeZ1KE1e"&gt;Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company complies with the accounting and reporting requirements of ASC 740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March&#160;31, 2026
or December&#160;31, 2025. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s only major tax
jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or
material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There
is currently no taxation imposed by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income
taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s unaudited condensed
financial statements. The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will
materially change over the next twelve months.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p id="xdx_843_ecustom--ShareRightsPolicyTextBlock_zHdUUloXKPB" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zdSSsGjHD152"&gt;Share Rights&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will account for the Public and Private Placement Share Rights, as defined below, to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and will classify the rights under equity treatment at their assigned value.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_840_ecustom--ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zc7c8qBHqmKb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zQ2NG8Xgpg93"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March&#160;31, 2026, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s  condensed balance sheets. As of March&#160;31, 2026, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_899_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zoIILdk9R1s4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zNqnQoGQVPg6" style="display: none"&gt;Schedule of redemption reflected in the balance sheet are reconciled&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gross proceeds&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OrdinarySharesSubjectToPossibleRedemptionBeginning_iS_c20260101__20260331_zGqajsbJ6Org" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, beginning"&gt;172,500,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Less:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ProceedsAllocatedToPublicWarrants_c20260101__20260331_zJI4JwteOc5d" style="text-align: right" title="Proceeds allocated to Public Warrants"&gt;(974,625&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Proceeds allocated to Public Rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--ProceedsAllocatedToPublicRights_c20260101__20260331_zmdESb3DQHug" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(4,398,750&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Public Shares issuance costs&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--PublicSharesIssuanceCosts_c20260101__20260331_zenmCSQsG95d" style="text-align: right" title="Public Shares issuance costs"&gt;(13,821,755&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Plus:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20260101__20260331_zcLNa3G2aT2d" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;20,055,836&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;Class&#160;A Ordinary Shares subject to possible redemption, March&#160;31, 2026&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_ecustom--OrdinarySharesSubjectToPossibleRedemptionBeginning_iE_c20260101__20260331_zNHNazBlvWKl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, ending"&gt;173,360,706&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AE_zMI8d5Bpdjnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_z3pVxNwxyTm" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;span id="xdx_86E_z5Qqf6iT11cj"&gt;Net Income per Ordinary Share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; text-indent: 0.25in"&gt;The Company
complies with accounting and disclosure requirements of ASC 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares,
which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Income and losses are shared pro rata between the two classes
of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average Ordinary Shares outstanding
for the respective period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; text-indent: 0.25in"&gt;With respect
to the accretion of Class A Ordinary Shares subject to possible redemption and consistent with ASC Topic 480-10-S99-3A, the Company treated
accretion in the same manner as a dividend paid to the shareholders in the calculation of the net income per ordinary share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; text-indent: 0.25in"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z9KDqWvVHxS6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B0_zx3LaqlCgv55" style="display: none"&gt;Schedule
    of earnings per share basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
March&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class B&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-style: italic; text-align: left"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"&gt;Allocation of net income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_z8CB91trrL96" title="Allocation of net income"&gt;422,970&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_z0O0EcG4Gotb" title="Allocation of net income"&gt;225,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic weighted average ordinary shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zgA7Wtm5xwnk" title="Weighted average shares outstanding of redeemable ordinary shares, Basic"&gt;10,165,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zqjFXdJStt2i" title="Weighted average shares outstanding of redeemable ordinary shares, Basic"&gt;5,416,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zqypE6PqrxY2" title="Basic net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_z9BGQdRdA6M1" title="Basic net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
March&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class B&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;i&gt;Diluted net income per ordinary share&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allocation of net income&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zCGhkTrihta8" title="Allocation of net income"&gt;414,112&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zCKERwszOeT4" title="Allocation of net income"&gt;234,236&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Basic and diluted weighted average ordinary shares outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zkKvZafz5Zkd" title="Weighted average shares outstanding of redeemable ordinary shares, Diluted"&gt;10,165,552&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zeJM1ZZyIyJ1" title="Weighted average shares outstanding of redeemable ordinary shares, Diluted"&gt;5,750,000&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Diluted net income per ordinary share&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zAs61oTlcXV" title="Diluted net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zhqYBBVtw30j" title="Diluted net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A4_zc72DzAN0UEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_84B_eus-gaap--ExtendedProductWarrantyPolicy_zxN6K1FAmx0e" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zVD1XkaCWSXh"&gt;Warrant Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will account for the warrants to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned value. There are &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z6d8Y8yMeBl8" title="Warrant outstanding"&gt;8,625,000&lt;/span&gt; Public Warrants (defined in Note 3) and &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zexZ0hYCSC3c" title="Warrant outstanding"&gt;139,733&lt;/span&gt; Private Placement Warrants (defined in Note 5) outstanding as of March&#160;31, 2026.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuQ18TsiIcp9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zJ9aiQB9IXdh"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Management
does not believe that recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000405">&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVd4t4WVSBOd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_86C_z2JVHbwNJWsk"&gt;&lt;b&gt;&lt;i&gt;Basis
                                            of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the period ended December&#160;31, 2025, as filed with the SEC on March&#160;27, 2026, as well as the Company&#x2019;s Current Report on Form 8-K filed with the SEC on February&#160;17, 2026. The interim results for the three months ended March&#160;31, 2026, are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2026, or for any future periods.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <spacs:EmergingGrowthCompanyPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000407">&lt;p id="xdx_84D_ecustom--EmergingGrowthCompanyPolicyTextBlock_zgRWBsUlk2Uf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zqNuaiScuSa7"&gt;Emerging Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Section&#160;102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</spacs:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2026-01-01to2026-03-31" id="Fact000409">&lt;p id="xdx_846_eus-gaap--UseOfEstimates_zmuYxuPctdkb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_ziwjI3goylxf"&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the unaudited condensed financial statements. Actual results could differ from those estimates.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000411">&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zYCh8W0taGjf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_z4Y2Yeunx4E2"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash and $&lt;span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20260331_zGFprr6luF2c" title="Cash equivalents"&gt;308,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20251231_zn9nhE9WC7hd" title="Cash equivalents"&gt;6,081&lt;/span&gt; of cash equivalents as of March&#160;31, 2026 and December&#160;31, 2025, respectively.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000413"
      unitRef="USD">308000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000415"
      unitRef="USD">6081</us-gaap:CashEquivalentsAtCarryingValue>
    <spacs:CashAndMarketableSecuritiesHeldIinTrustAccountPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000423">&lt;p id="xdx_845_ecustom--CashAndMarketableSecuritiesHeldIinTrustAccountPolicyTextBlock_zdCeeeKCW3Af" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zWvzTKaHDAob"&gt;Cash and marketable securities held in Trust Account&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;As of March&#160;31, 2026, the assets held in the Trust Account, amounting to $&lt;span id="xdx_90B_eus-gaap--InvestmentsAndCash_iI_c20260331_zQZqiZHTEdHd" title="Cash and marketable securities held in Trust Account"&gt;173,360,706&lt;/span&gt;, were held in money cash and marketable securities held in Trust Account. As of December&#160;31, 2025, there were no assets held in the Trust Account. The investments held in money market funds are classified as trading securities. Gains and losses resulting from the change in fair value of these securities are included in interest earned on marketable securities held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</spacs:CashAndMarketableSecuritiesHeldIinTrustAccountPolicyTextBlock>
    <us-gaap:InvestmentsAndCash
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000425"
      unitRef="USD">173360706</us-gaap:InvestmentsAndCash>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2026-01-01to2026-03-31" id="Fact000427">&lt;p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zapHrkBYI3n4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zqa5hoXPj0g7"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $&lt;span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20260331_zQ5k7qV2KaU5" title="FDIC Coverage limit"&gt;250,000&lt;/span&gt;. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000429"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <spacs:OfferingCostsPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000431">&lt;p id="xdx_846_ecustom--OfferingCostsPolicyTextBlock_zZDlKBrx9Tci" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zKn1YQgkzdp5"&gt;Offering Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A Ordinary Shares, warrants, and rights, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and rights and then to the Class A Ordinary Shares. Offering costs allocated to the Public Shares are charged to temporary equity, and offering costs allocated to the warrants and share rights in the Units, the Private Placement Units, and the Restricted Class A Ordinary Shares are charged to shareholders&#x2019; deficit, as the warrants and rights included in the Units and Private Placement Units, after management&#x2019;s evaluation, are accounted for under equity treatment.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</spacs:OfferingCostsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2026-01-01to2026-03-31" id="Fact000433">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9PqJibkBgmk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_z2XWPcBSgZs7"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the  condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000435">&lt;p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_z8mpjpCnbgPf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zgBizeZ1KE1e"&gt;Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company complies with the accounting and reporting requirements of ASC 740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March&#160;31, 2026
or December&#160;31, 2025. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s only major tax
jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or
material deviation from its position. The Company is subject to tax examinations by major taxing authorities since inception. There
is currently no taxation imposed by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income
taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s unaudited condensed
financial statements. The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will
materially change over the next twelve months.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













</us-gaap:IncomeTaxPolicyTextBlock>
    <spacs:ShareRightsPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000443">&lt;p id="xdx_843_ecustom--ShareRightsPolicyTextBlock_zHdUUloXKPB" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zdSSsGjHD152"&gt;Share Rights&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will account for the Public and Private Placement Share Rights, as defined below, to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and will classify the rights under equity treatment at their assigned value.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</spacs:ShareRightsPolicyTextBlock>
    <spacs:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000445">&lt;p id="xdx_840_ecustom--ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zc7c8qBHqmKb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zQ2NG8Xgpg93"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March&#160;31, 2026, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s  condensed balance sheets. As of March&#160;31, 2026, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_899_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zoIILdk9R1s4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zNqnQoGQVPg6" style="display: none"&gt;Schedule of redemption reflected in the balance sheet are reconciled&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gross proceeds&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OrdinarySharesSubjectToPossibleRedemptionBeginning_iS_c20260101__20260331_zGqajsbJ6Org" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, beginning"&gt;172,500,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Less:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ProceedsAllocatedToPublicWarrants_c20260101__20260331_zJI4JwteOc5d" style="text-align: right" title="Proceeds allocated to Public Warrants"&gt;(974,625&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Proceeds allocated to Public Rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--ProceedsAllocatedToPublicRights_c20260101__20260331_zmdESb3DQHug" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(4,398,750&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Public Shares issuance costs&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--PublicSharesIssuanceCosts_c20260101__20260331_zenmCSQsG95d" style="text-align: right" title="Public Shares issuance costs"&gt;(13,821,755&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Plus:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20260101__20260331_zcLNa3G2aT2d" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;20,055,836&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;Class&#160;A Ordinary Shares subject to possible redemption, March&#160;31, 2026&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_ecustom--OrdinarySharesSubjectToPossibleRedemptionBeginning_iE_c20260101__20260331_zNHNazBlvWKl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, ending"&gt;173,360,706&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AE_zMI8d5Bpdjnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</spacs:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000447">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zoIILdk9R1s4" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BF_zNqnQoGQVPg6" style="display: none"&gt;Schedule of redemption reflected in the balance sheet are reconciled&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Gross proceeds&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OrdinarySharesSubjectToPossibleRedemptionBeginning_iS_c20260101__20260331_zGqajsbJ6Org" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, beginning"&gt;172,500,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Less:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ProceedsAllocatedToPublicWarrants_c20260101__20260331_zJI4JwteOc5d" style="text-align: right" title="Proceeds allocated to Public Warrants"&gt;(974,625&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Proceeds allocated to Public Rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--ProceedsAllocatedToPublicRights_c20260101__20260331_zmdESb3DQHug" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(4,398,750&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Public Shares issuance costs&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--PublicSharesIssuanceCosts_c20260101__20260331_zenmCSQsG95d" style="text-align: right" title="Public Shares issuance costs"&gt;(13,821,755&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Plus:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 0.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--AccretionOfCarryingValueToRedemptionValue_c20260101__20260331_zcLNa3G2aT2d" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;20,055,836&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; padding-bottom: 1.25pt"&gt;Class&#160;A Ordinary Shares subject to possible redemption, March&#160;31, 2026&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_ecustom--OrdinarySharesSubjectToPossibleRedemptionBeginning_iE_c20260101__20260331_zNHNazBlvWKl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, ending"&gt;173,360,706&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <spacs:OrdinarySharesSubjectToPossibleRedemptionBeginning
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000449"
      unitRef="USD">172500000</spacs:OrdinarySharesSubjectToPossibleRedemptionBeginning>
    <spacs:ProceedsAllocatedToPublicWarrants
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000451"
      unitRef="USD">-974625</spacs:ProceedsAllocatedToPublicWarrants>
    <spacs:ProceedsAllocatedToPublicRights
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000453"
      unitRef="USD">-4398750</spacs:ProceedsAllocatedToPublicRights>
    <spacs:PublicSharesIssuanceCosts
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000455"
      unitRef="USD">-13821755</spacs:PublicSharesIssuanceCosts>
    <spacs:AccretionOfCarryingValueToRedemptionValue
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000457"
      unitRef="USD">20055836</spacs:AccretionOfCarryingValueToRedemptionValue>
    <spacs:OrdinarySharesSubjectToPossibleRedemptionBeginning
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000459"
      unitRef="USD">173360706</spacs:OrdinarySharesSubjectToPossibleRedemptionBeginning>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000461">&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_z3pVxNwxyTm" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;span id="xdx_86E_z5Qqf6iT11cj"&gt;Net Income per Ordinary Share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; text-indent: 0.25in"&gt;The Company
complies with accounting and disclosure requirements of ASC 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares,
which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Income and losses are shared pro rata between the two classes
of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average Ordinary Shares outstanding
for the respective period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; text-indent: 0.25in"&gt;With respect
to the accretion of Class A Ordinary Shares subject to possible redemption and consistent with ASC Topic 480-10-S99-3A, the Company treated
accretion in the same manner as a dividend paid to the shareholders in the calculation of the net income per ordinary share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; text-indent: 0.25in"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z9KDqWvVHxS6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B0_zx3LaqlCgv55" style="display: none"&gt;Schedule
    of earnings per share basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
March&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class B&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-style: italic; text-align: left"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"&gt;Allocation of net income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_z8CB91trrL96" title="Allocation of net income"&gt;422,970&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_z0O0EcG4Gotb" title="Allocation of net income"&gt;225,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic weighted average ordinary shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zgA7Wtm5xwnk" title="Weighted average shares outstanding of redeemable ordinary shares, Basic"&gt;10,165,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zqjFXdJStt2i" title="Weighted average shares outstanding of redeemable ordinary shares, Basic"&gt;5,416,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zqypE6PqrxY2" title="Basic net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_z9BGQdRdA6M1" title="Basic net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
March&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class B&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;i&gt;Diluted net income per ordinary share&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allocation of net income&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zCGhkTrihta8" title="Allocation of net income"&gt;414,112&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zCKERwszOeT4" title="Allocation of net income"&gt;234,236&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Basic and diluted weighted average ordinary shares outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zkKvZafz5Zkd" title="Weighted average shares outstanding of redeemable ordinary shares, Diluted"&gt;10,165,552&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zeJM1ZZyIyJ1" title="Weighted average shares outstanding of redeemable ordinary shares, Diluted"&gt;5,750,000&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Diluted net income per ordinary share&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zAs61oTlcXV" title="Diluted net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zhqYBBVtw30j" title="Diluted net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A4_zc72DzAN0UEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000469">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z9KDqWvVHxS6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B0_zx3LaqlCgv55" style="display: none"&gt;Schedule
    of earnings per share basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
March&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class B&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-style: italic; text-align: left"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"&gt;Allocation of net income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_z8CB91trrL96" title="Allocation of net income"&gt;422,970&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_z0O0EcG4Gotb" title="Allocation of net income"&gt;225,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic weighted average ordinary shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zgA7Wtm5xwnk" title="Weighted average shares outstanding of redeemable ordinary shares, Basic"&gt;10,165,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zqjFXdJStt2i" title="Weighted average shares outstanding of redeemable ordinary shares, Basic"&gt;5,416,667&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zqypE6PqrxY2" title="Basic net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_z9BGQdRdA6M1" title="Basic net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
March&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Class B&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;i&gt;Diluted net income per ordinary share&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Numerator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Allocation of net income&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zCGhkTrihta8" title="Allocation of net income"&gt;414,112&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zCKERwszOeT4" title="Allocation of net income"&gt;234,236&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Denominator&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Basic and diluted weighted average ordinary shares outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zkKvZafz5Zkd" title="Weighted average shares outstanding of redeemable ordinary shares, Diluted"&gt;10,165,552&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zeJM1ZZyIyJ1" title="Weighted average shares outstanding of redeemable ordinary shares, Diluted"&gt;5,750,000&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.25pt"&gt;Diluted net income per ordinary share&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zAs61oTlcXV" title="Diluted net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zhqYBBVtw30j" title="Diluted net income per redeemable ordinary share"&gt;0.04&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap; padding-bottom: 1.25pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000471"
      unitRef="USD">422970</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="0"
      id="Fact000473"
      unitRef="USD">225378</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000475"
      unitRef="Shares">10165552</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000477"
      unitRef="Shares">5416667</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000479"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000481"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000483"
      unitRef="USD">414112</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="0"
      id="Fact000485"
      unitRef="USD">234236</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000487"
      unitRef="Shares">10165552</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000489"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-03-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000491"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-03-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000493"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ExtendedProductWarrantyPolicy contextRef="From2026-01-01to2026-03-31" id="Fact000495">&lt;p id="xdx_84B_eus-gaap--ExtendedProductWarrantyPolicy_zxN6K1FAmx0e" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zVD1XkaCWSXh"&gt;Warrant Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will account for the warrants to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned value. There are &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z6d8Y8yMeBl8" title="Warrant outstanding"&gt;8,625,000&lt;/span&gt; Public Warrants (defined in Note 3) and &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zexZ0hYCSC3c" title="Warrant outstanding"&gt;139,733&lt;/span&gt; Private Placement Warrants (defined in Note 5) outstanding as of March&#160;31, 2026.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:ExtendedProductWarrantyPolicy>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000497"
      unitRef="Shares">8625000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      id="Fact000499"
      unitRef="Shares">139733</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000501">&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuQ18TsiIcp9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zJ9aiQB9IXdh"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Management
does not believe that recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <spacs:PublicOfferingTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000503">&lt;p id="xdx_802_ecustom--PublicOfferingTextBlock_zu0lZjjUTCR8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 3 &#x2014; &lt;span id="xdx_82D_z4IYuL1rlNl6"&gt;Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Pursuant to the Initial Public Offering on February&#160;9, 2026, the Company sold &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zsDylKJIO89e" title="Sale of units in public offering"&gt;17,250,000&lt;/span&gt; units at a price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zU0Z2ma1G2Ti" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Unit, which includes a full exercise of the underwriters&#x2019; over-allotment option. Each Unit consists of one Class A Ordinary Share (such Class A Ordinary Shares included in the Units being offered, the &#x201c;Public Shares&#x201d;), one-half of one redeemable warrant (&#x201c;Public Warrants&#x201d;), and one right to receive one-fifth (1/5) of a Class A ordinary share (each, a &#x201c;Public Share Right&#x201d;) upon the consummation of an initial Business Combination (see Note 7).&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













</spacs:PublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000505"
      unitRef="Shares">17250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-09_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000507"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000515">&lt;p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zYcO4sA6ymzl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 4 &#x2014; &lt;span id="xdx_824_zT3HMUQrr7sl"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;On June&#160;28, 2025 the Sponsor purchased &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZyzYb969OTa" title="Aggregate value of shares"&gt;5,750,000&lt;/span&gt; shares of the Company&#x2019;s Class B Ordinary Shares, par value $&lt;span id="xdx_900_eus-gaap--SharePrice_iI_c20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zW2TUXYIRybl" title="Share Price"&gt;0.0001&lt;/span&gt; (&#x201c;Class B Ordinary Shares&#x201d;), for an aggregate price of $&lt;span id="xdx_90F_ecustom--AggregatedPrice_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zpZIdQC7KMT4" title="Aggregated price"&gt;25,000&lt;/span&gt; (the &#x201c;Founder Shares&#x201d;), up to &lt;span id="xdx_907_ecustom--SharesSubjectToForfeiture_c20250601__20250628_zmczKM8CAN4a" title="Shares subject to forfeiture"&gt;750,000&lt;/span&gt; of which are subject to forfeiture. The Founder Shares will automatically convert into Class A Ordinary Shares at the time of the Company&#x2019;s initial Business Combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their Class B Ordinary Shares into an equal number of Class A Ordinary Shares, subject to adjustment, at any time. The initial shareholders had agreed to forfeit up to &lt;span id="xdx_907_ecustom--SharesSubjectToForfeiture_c20250601__20250628_zKrfPi3lVe5k" title="Shares subject to forfeiture"&gt;750,000&lt;/span&gt; Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters. On February&#160;9, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, those &lt;span id="xdx_90E_ecustom--SharesSubjectToForfeiture_c20260101__20260331__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zkCFZqv4PYvj" title="Shares subject to forfeiture"&gt;750,000&lt;/span&gt; Founder Shares are no longer subject to forfeiture.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Simultaneously with the closing of the Initial Public Offering, the Sponsor and direct institutional investors purchased (a) &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYpCohBS8tbh" title="Sale of units in public offering"&gt;279,465&lt;/span&gt; Private Placement Units and (b) &lt;span id="xdx_901_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zreFE4tgMfLb" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;768,529&lt;/span&gt; Restricted Class A Ordinary Shares, for an aggregate purchase price of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfWarrants_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zZgY8ci9F4R1" title="Gross proceeds"&gt;2,794,650&lt;/span&gt; in Private Placement.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The initial shareholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination or (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination that results in all of the public shareholders having the right to exchange their Ordinary Shares for cash, securities or other property. Notwithstanding the foregoing, the converted Class A Ordinary Shares will be released from the lock-up if (x)  the last sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property. However, if after the initial Business Combination there is a transaction whereby all the outstanding Class A Ordinary Shares are exchanged or redeemed for cash or another issuer&#x2019;s shares, then the Founder Shares shall be permitted to participate.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Promissory Note &#x2014; Related Party&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;On June&#160;28, 2025, the Sponsor agreed to loan the Company an aggregate of up to $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20250628_zgQdPVki5wG4" title="Aggregate amount"&gt;375,000&lt;/span&gt; to be used for a portion of the expenses of the Initial Public Offering. The note is non-interest-bearing, unsecured and due at the earlier of December&#160;31, 2025, or the closing of the Initial Public Offering. On February&#160;9, 2026, the Company repaid the note balance in full of $&lt;span id="xdx_90D_eus-gaap--RepaymentsOfNotesPayable_c20260101__20260331_z5hGCNBUbOW6" title="Repayment of notes payable"&gt;242,513&lt;/span&gt;. Borrowings under this note are no longer available.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Due from Sponsor&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Sponsor owes the Company $&lt;span id="xdx_90E_ecustom--DueFromSponsor_iI_c20260331_zQcip5gQtri9" title="Due from Sponsor"&gt;192,493&lt;/span&gt; for overpayment of the promissory note &#x2013; related party, which is due on demand.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Support Services&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Commencing on the effective date, January&#160;30, 2026, the Company entered into an agreement with an affiliate of the Sponsor to pay an aggregate of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20260130_zqTwndKGWY1h" title="Aggregate amount"&gt;10,000&lt;/span&gt; per month for office space, utilities, and secretarial and administrative support and will cease paying until the earlier of the consummation of the Business Combination or its liquidation. As of March&#160;31, 2026, the Company incurred $&lt;span id="xdx_90A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_c20260331_zhVlgRA71Mi7" title="Accrued expenses"&gt;20,000&lt;/span&gt; for these fees which was included in the accrued expenses in the accompanying condensed balance sheets.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Related Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $&lt;span id="xdx_905_ecustom--WorkingCapitalLoans_iI_c20260331_zIkB4JxhOiB9" title="Working capital loans"&gt;1,000,000&lt;/span&gt; of such Working Capital Loans may be convertible into Private Placement Units of the post-Business Combination entity at a price of $10.00 per unit. Such units would be identical to the Private Placement Units. As of March&#160;31, 2026 and December&#160;31, 2025, no such Working Capital Loans were outstanding.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-06-012025-06-28_custom_SponsorMember"
      decimals="0"
      id="Fact000517"
      unitRef="USD">5750000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2025-06-28_custom_SponsorMember"
      decimals="INF"
      id="Fact000519"
      unitRef="USDPShares">0.0001</us-gaap:SharePrice>
    <spacs:AggregatedPrice
      contextRef="From2025-06-012025-06-28_custom_FounderSharesMember"
      decimals="0"
      id="Fact000521"
      unitRef="USD">25000</spacs:AggregatedPrice>
    <spacs:SharesSubjectToForfeiture
      contextRef="From2025-06-012025-06-28"
      decimals="INF"
      id="Fact000523"
      unitRef="Shares">750000</spacs:SharesSubjectToForfeiture>
    <spacs:SharesSubjectToForfeiture
      contextRef="From2025-06-012025-06-28"
      decimals="INF"
      id="Fact000525"
      unitRef="Shares">750000</spacs:SharesSubjectToForfeiture>
    <spacs:SharesSubjectToForfeiture
      contextRef="From2026-01-012026-03-31_custom_FounderMember"
      decimals="INF"
      id="Fact000527"
      unitRef="Shares">750000</spacs:SharesSubjectToForfeiture>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000529"
      unitRef="Shares">279465</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000531"
      unitRef="Shares">768529</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000533"
      unitRef="USD">2794650</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-28"
      decimals="0"
      id="Fact000535"
      unitRef="USD">375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000537"
      unitRef="USD">242513</us-gaap:RepaymentsOfNotesPayable>
    <spacs:DueFromSponsor
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000539"
      unitRef="USD">192493</spacs:DueFromSponsor>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-01-30"
      decimals="0"
      id="Fact000541"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000543"
      unitRef="USD">20000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <spacs:WorkingCapitalLoans
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000551"
      unitRef="USD">1000000</spacs:WorkingCapitalLoans>
    <spacs:PrivatePlacementUnitsRestrictedClassAOrdinarySharesTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000553">&lt;p id="xdx_804_ecustom--PrivatePlacementUnitsRestrictedClassAOrdinarySharesTextBlock_zMyyt2uM8Qs1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 5 &#x2014; &lt;span id="xdx_824_zZHgQotCxB04"&gt;Private Placement Units; Restricted Class A Ordinary Shares&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Simultaneously with the consummation of the Initial Public Offering on February&#160;9, 2026, the Sponsor and direct institutional investors purchased an aggregate of (a) &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlcTIKs8dtol" title="Sale of units in public offering"&gt;279,465&lt;/span&gt; Private Placement Units and (b) &lt;span id="xdx_902_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ztT8Ug3yj2vf" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;768,529&lt;/span&gt; Restricted Class A Ordinary Shares, par value $&lt;span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z4cMyPbriQy" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share, of the Company, which shares shall be subject to (i) certain restrictions which only lapse upon the consummation of the initial Business Combination and (ii) surrender for nil consideration if an initial Business Combination is not consummated in accordance with the amended and restated memorandum and articles of association, at a price of $10.00 for each private placement security, generating gross proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfWarrants_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGac6nI3kN6f" title="Gross proceeds"&gt;2,794,650&lt;/span&gt;, in a Private Placement. Among the (i) &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwCKKUGeBBW6" title="Sale of units in public offering"&gt;279,465&lt;/span&gt; Private Placement Units and (ii) &lt;span id="xdx_90A_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5Zb5P5UG6E4" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;768,529&lt;/span&gt; Restricted Class A Ordinary Shares purchased by the Sponsor and direct institutional investors in the Private Placement, (w) institutional non-managing sponsor members indirectly hold &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_ztZLxNsSFqH3" title="Sale of units in public offering"&gt;110,000&lt;/span&gt; Private Placement Units and &lt;span id="xdx_906_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z15MoQQXaGi8" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;302,500&lt;/span&gt; Restricted Class A Ordinary Shares, (x) individual non-managing sponsor members indirectly hold 79,465 Private Placement Units, (y) managing sponsor members indirectly hold &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--ManagingSponsorMember_zJWpTnnQc9L8" title="Sale of units in public offering"&gt;40,000&lt;/span&gt; Private Placement Units and &lt;span id="xdx_900_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--ManagingSponsorMember_z3s00eI3XH33" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;328,529&lt;/span&gt; Restricted Class A Ordinary Shares, and (z) direct institutional investors directly hold &lt;span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--InvestorsMember_zBODE5nuFK8k" title="Sale of units in public offering"&gt;50,000&lt;/span&gt; Private Placement Units and &lt;span id="xdx_900_ecustom--RestrictedClassOrdinarySharesWhichSharesShallBeSubject_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--InvestorsMember_zwfpyljm0RYd" title="Restricted Class A ordinary shares, which shares shall be subject"&gt;137,500&lt;/span&gt; Restricted Class A Ordinary Shares. Subject to each direct institutional investor and each non-managing sponsor member (through the sponsor) purchasing the Private Placement Securities allocated to them, the Sponsor has (i) sold, assigned and transferred &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zyf3aiB4NiVl" title="Sale of units in public offering"&gt;500,000&lt;/span&gt; Founder Shares to the direct institutional investors for a nominal purchase price and (ii) issued Class A membership units representing &lt;span id="xdx_901_ecustom--FounderSharesIssued_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIXhdmpfk4wj" title="Founder shares issued"&gt;1,894,650&lt;/span&gt; Founder Shares to the non-managing sponsor members for a nominal purchase price. Following these issuances, the direct institutional investors and non-managing sponsor members, in the aggregate, hold interests in &lt;span id="xdx_901_ecustom--FounderSharesIssued_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zOVzIJ7rNC68" title="Founder shares issued"&gt;2,394,650&lt;/span&gt; Founder Shares.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Securities held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), the Founder Shares (as defined above) and private placement shares will not be entitled to liquidating distributions from the Trust Account, and the private placement warrants and private placement rights will expire worthless and the Restricted Class A Ordinary Shares will be surrendered for nil consideration to the Company. The Sponsor and the Company&#x2019;s officers and directors have agreed, subject to limited exceptions, that the Private Placement Units (including the Class A Ordinary Shares issuable upon exercise of the Private Placement Units) will not be transferable, assignable or salable until 30 days after the completion of our initial Business Combination, and the Restricted Class A Ordinary Shares will not be transferable, assignable, or salable until 30 days after the completion of our initial Business Combination.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Each Private Placement Unit consists of one Class A Ordinary Share, one-half of one redeemable warrant (&#x201c;Private Placement Warrant&#x201d;), and one right to receive one-fifth (1/5) of a Class A Ordinary Share (&#x201c;Private Placement Share Right&#x201d;) upon the consummation of an initial Business Combination.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













</spacs:PrivatePlacementUnitsRestrictedClassAOrdinarySharesTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000555"
      unitRef="Shares">279465</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000557"
      unitRef="Shares">768529</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000559"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000561"
      unitRef="USD">2794650</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000563"
      unitRef="Shares">279465</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000565"
      unitRef="Shares">768529</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      id="Fact000567"
      unitRef="Shares">110000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      id="Fact000569"
      unitRef="Shares">302500</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_ManagingSponsorMember"
      decimals="INF"
      id="Fact000571"
      unitRef="Shares">40000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_ManagingSponsorMember"
      decimals="INF"
      id="Fact000573"
      unitRef="Shares">328529</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact000575"
      unitRef="Shares">50000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject
      contextRef="From2026-02-012026-02-09_us-gaap_PrivatePlacementMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact000577"
      unitRef="Shares">137500</spacs:RestrictedClassOrdinarySharesWhichSharesShallBeSubject>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-06-012025-06-28_custom_FounderSharesMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000579"
      unitRef="Shares">500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <spacs:FounderSharesIssued
      contextRef="From2025-06-012025-06-28_custom_FounderSharesMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000581"
      unitRef="Shares">1894650</spacs:FounderSharesIssued>
    <spacs:FounderSharesIssued
      contextRef="From2025-06-012025-06-28_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000583"
      unitRef="Shares">2394650</spacs:FounderSharesIssued>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000591">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zElTW63MTzTd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 6 &#x2014; &lt;span id="xdx_821_zWYRzbJIO3ma"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the Israel-US conflict with Iran. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#x201c;NATO&#x201d;) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-US conflict with Iran and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel, Iran and their neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of the Israel-US conflict with Iran and subsequent sanctions or related actions, could adversely affect the Company&#x2019;s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The holders of (i) Founder Shares, which were issued in a private placement prior to the closing of the Initial Public Offering, (ii) Private Placement Units which will be issued in a private placement simultaneously with the closing of the Initial Public Offering and the Class A Ordinary Shares, private placement warrants, and private placement rights underlying such Private Placement Units and the Class A Ordinary Shares underlying such warrants and rights, (iii) Restricted Class A Ordinary Shares, and (iv) Private Placement Units that may be issued upon conversion of Working Capital Loans and the Class A Ordinary Shares, private placement warrants, and private placement rights underlying such Private Placement Units and the Class A Ordinary Shares underlying such warrants and rights are entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to Class A Ordinary Shares) pursuant to a registration rights agreement signed on the date of the Initial Public Offering. These holders will be entitled to certain demand and &#x201c;piggyback&#x201d; registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Underwriters&#x2019; Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260331_zNcK8FXPaR8d" title="Sale of units in initial public offering"&gt;2,250,000&lt;/span&gt; units to cover over-allotments, if any. On February&#160;9, 2026, the underwriters exercised their over-allotment option, closing on the &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zJsqEgs7wWP5" title="Sale of units in public offering"&gt;2,250,000&lt;/span&gt; additional Units simultaneously with the Initial Public Offering.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The underwriters were entitled to an underwriting discount of $0.20 per unit, or $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260101__20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHZSwDw6B77" title="Gross proceeds from public offering"&gt;3,450,000&lt;/span&gt; in the aggregate, which was paid upon the closing of the Initial Public Offering. The underwriters paid the Company an aggregate amount of $&lt;span id="xdx_90E_ecustom--UnderwritersReimbursement_c20260101__20260331_zsX7WvnOR1Ob" title="Underwriters reimbursement"&gt;2,156,250&lt;/span&gt; at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Additionally, the underwriters are entitled to $&lt;span id="xdx_900_eus-gaap--OtherUnderwritingExpense_pp0p0_c20260101__20260331_zVa1mGTglnif" title="Deferred underwriting fees"&gt;12,075,000&lt;/span&gt; of deferred underwriting commissions; provided, however, that such $0.70 per unit shall be due solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection with the consummation of the initial Business Combination.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000593"
      unitRef="Shares">2250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-012026-02-09_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000595"
      unitRef="Shares">2250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-01-012026-03-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000603"
      unitRef="USD">3450000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <spacs:UnderwritersReimbursement
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000605"
      unitRef="USD">2156250</spacs:UnderwritersReimbursement>
    <us-gaap:OtherUnderwritingExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000607"
      unitRef="USD">12075000</us-gaap:OtherUnderwritingExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000609">&lt;p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zcTl3I3oNEq6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 7 &#x2014; &lt;span id="xdx_828_zov9bsHpoTwj"&gt;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Ordinary Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Preference Shares &#x2014;&lt;/i&gt;&lt;/b&gt; The Company is authorized to issue &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20260331_zkHiCpid2g9g" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231_zEN01t4bc5Xh" title="Preferred stock, shares authorized"&gt;5,000,000&lt;/span&gt;&lt;/span&gt; preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. As of March&#160;31, 2026 and December&#160;31, 2025, there were &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20260331_z7wt2G5hFslb" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20260331_ze3DHJVYiFYb" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_do_c20251231_zQhJaCbpAvr9" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20251231_zKt9aLKnmij8" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Class A Ordinary Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8wn4fCGrEQk" title="Common stock, shares authorized"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zhNM2PTivxlf" title="Common stock, shares authorized"&gt;500,000,000&lt;/span&gt;&lt;/span&gt; Class A Ordinary Shares with a par value of $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHRkmJXt5Fwi" title="Common stock, par value"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9HPNKEa8aad" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share. As of March&#160;31, 2026 and December&#160;31, 2025, there were &lt;span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_ztNpmbCzWtx3" title="Common stock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z1V6evMtdhL1" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuNAEAd2VGSh" title="Common stock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zgNwNTvt7Vb8" title="Common stock, shares outstanding"&gt;1,047,994&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; Class A Ordinary Shares issued and outstanding (excluding 17,250,000 shares subject to possible redemption).&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Class B Ordinary Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue &lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zV5EMLPSmJJ1" title="Common stock, shares authorized"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znWEWUDmTmQc" title="Common stock, shares authorized"&gt;50,000,000&lt;/span&gt;&lt;/span&gt; Class B Ordinary Shares with a par value of $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zc8hxO0ljQc9" title="Common stock, par value"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zMENCvk7qB9a" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share. Holders of Class B Ordinary Shares are entitled to one vote for each share. On June&#160;28, 2025, the Sponsor purchased &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z3EDBatralQa" title="Aggregate value of shares"&gt;5,750,000&lt;/span&gt; shares of the Company&#x2019;s Class B Ordinary Shares for an aggregate price of $&lt;span id="xdx_90F_ecustom--AggregatedPrice_c20250601__20250628__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zqrhy31gOTJj" title="Aggregated price"&gt;25,000&lt;/span&gt;, or approximately $0.004 per share. As of March&#160;31, 2026 and December&#160;31, 2025, there were &lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9j37pnUZ0me" title="Common stock, shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zeCdf10GrJdh" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzLUxFh5GZL5" title="Common stock, shares issued"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpUGeNGG57Gk" title="Common stock, shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; Class B Ordinary Shares outstanding.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Holders of Class A Ordinary Shares and Class B Ordinary Shares will vote together as a single class on all other matters submitted to a vote of shareholders except as required by law.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A Ordinary Shares, or any equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering (including pursuant to the over-allotment option) and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B Ordinary Shares shall convert into Class A Ordinary Shares will be adjusted (unless the holders of a majority of the outstanding Class B Ordinary Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Ordinary Shares issuable upon conversion of all Class B Ordinary Shares will equal, in the aggregate, 25% of the sum of the total number of all Class A Ordinary Shares issued upon the completion of the Initial Public Offering (irrespective of whether or not such Class A Ordinary Shares are redeemed in connection with the initial Business Combination) (including any Class A Ordinary Shares issued pursuant to the over-allotment option and excluding any Class A Ordinary Shares underlying any units our initial shareholders may purchase in this offering and the Class A Ordinary Shares underlying the Private Placement Securities issued to our sponsor) plus all Class A Ordinary Shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (including any Class A Ordinary Shares issued pursuant to a forward purchase agreement), excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination, any private placement-equivalent shares issued to our sponsor or an affiliate of our sponsor, members of the Company&#x2019;s management team or any of their affiliates upon conversion of Working Capital Loans made to us. Holders of Founder Shares may also elect to convert their Class B Ordinary Shares into an equal number of Class A Ordinary Shares, subject to adjustment as provided above, at any time.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;As of March&#160;31, 2026, there were &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSe5oc15jrfg" title="Warrant outstanding"&gt;8,625,000&lt;/span&gt; Public Warrants and &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zp8YrMuPKgEb" title="Warrant outstanding"&gt;139,733&lt;/span&gt; Private Placement Warrants outstanding. Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5962cV20and" title="Exercise price of warrants"&gt;11.50&lt;/span&gt; per share, subject to adjustment as discussed below, at any time commencing &lt;span id="xdx_901_eus-gaap--FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod_dtD_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zaeyk9LiNn28" title="Redemption period"&gt;30&lt;/span&gt; days after the completion of our initial Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the Class A
Ordinary Shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits
holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are
registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant
to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class A Ordinary Shares. This means only
a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units
and only whole warrants will trade. Accordingly, unless holders purchase at least two units (or additional multiples of two), they will
not be able to receive or trade whole warrants. The warrants will expire five years after the completion of our initial Business Combination,
at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company
will not be obligated to deliver any Class A Ordinary Shares pursuant to the exercise of a warrant and will have no obligation to settle
such warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary Shares underlying
the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below
with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share
upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed
to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled
to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash
settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing
such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company
registered the Class A Ordinary Shares issuable upon exercise of the warrants in the registration statement effective January&#160;30,
2026 (SEC Registration No. 333-290414), because the warrants will become exercisable &lt;span id="xdx_907_eus-gaap--FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod_dtD_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zaIh23qZPrh5"&gt;30
&lt;/span&gt;days after the completion of our initial Business Combination, which may be within one year of this offering. However, because
the warrants will be exercisable until their expiration date of up to five years after the completion of our initial Business Combination,
in order to comply with the requirements of Section&#160;10(a)(3) of the Securities Act following the consummation of our initial Business
Combination, under the terms of the warrant agreement, the Company has agreed that, as soon as practicable, but in no event later than
20 business days, after the closing of our initial Business Combination, the Company will use commercially reasonable efforts to file
with the SEC a post-effective amendment to the registration statement or a new registration statement covering the registration under
the Securities Act of the Class A Ordinary Shares issuable upon exercise of the warrants and thereafter will use commercially reasonable
efforts to cause the same to become effective within 60 business days following our initial Business Combination and to maintain a current
prospectus relating to the Class A Ordinary Shares issuable upon exercise of the warrants until the expiration of the warrants in accordance
with the provisions of the warrant agreement. If a registration statement covering the Class A Ordinary Shares issuable upon exercise
of the warrants is not effective by the sixtieth (60) business day after the closing of our initial Business Combination, warrant holders
may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain
an effective registration statement, exercise warrants on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9) of the
Securities Act or another exemption. Notwithstanding the above, if our Class A Ordinary Shares are at the time of any exercise of a warrant
not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1)
of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a &#x201c;cashless
basis&#x201d; in accordance with Section&#160;3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will
not be required to file or maintain in effect a registration statement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;in whole and not in part;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;at a price of $&lt;span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_znrAht1e3Jgl" title="Redemption price per share"&gt;0.01&lt;/span&gt; per warrant;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;upon a minimum of 30 days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;); and&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;if, and only if, the closing price of the Class A Ordinary Shares equals or exceeds $&lt;span id="xdx_90C_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zG4vw90omwd4" title="Warrant redemption condition minimum share price"&gt;18.00&lt;/span&gt; per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#x201c;&#x2014; &lt;i&gt;Redemption Procedures - Anti-dilution Adjustments&lt;/i&gt;&#x201d;) for any &lt;span id="xdx_905_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zewigEjsgxVj" title="Threshold trading days for redemption of warrants"&gt;20&lt;/span&gt; trading days within a &lt;span id="xdx_909_ecustom--ThresholdConsecutiveTradingDaysForRedemptionOfWarrants_dtD_c20260101__20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zEAJGhPieV9l" title="Threshold consecutive trading days for redemption of warrants"&gt;30&lt;/span&gt;-trading day period commencing at least 150 days after completion of our initial Business Combination and ending three business days before the Company sends the notice of redemption to the warrant holders.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance
of the Class A Ordinary Shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class
A Ordinary Shares is available throughout the measurement period. If and when the warrants become redeemable by the Company, the Company
may not exercise its redemption right if the issuance of Ordinary Shares upon exercise of the warrants is not exempt from registration
or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company
will use our best efforts to register or qualify such Ordinary Shares under the blue sky laws of the state of residence in those states
in which the warrants were offered by us in this offering. The Company has established the last of the redemption criterion discussed
above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the
foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled
to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A Ordinary Shares may fall
below the $18.00 redemption trigger price (as adjusted for share subdivisions, share capitalizations, share consolidations, reorganizations,
recapitalizations and the like) as well as the $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxAdZOXVj015" title="Exercise price of warrants"&gt;11.50&lt;/span&gt; warrant exercise price after the redemption notice is issued.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#x2019;s affiliates), to the warrant agent&#x2019;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the Class A Ordinary Shares outstanding immediately after giving effect to such exercise.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;&lt;i&gt;Anti-dilution
Adjustments.&lt;/i&gt; If the number of outstanding Class A Ordinary Shares is increased by a share capitalization payable in Class A Ordinary
Shares, or by a sub-division of Ordinary Shares or other similar event, then, on the effective date of such share capitalization, subdivision
or similar event, the number of Class A Ordinary Shares issuable on exercise of each warrant will be increased in proportion to such
increase in the outstanding Ordinary Shares. A rights offering made to all or substantially all holders of Ordinary Shares entitling
holders to purchase Class A Ordinary Shares at a price less than the fair market value will be deemed a share capitalization of a number
of Class A Ordinary Shares equal to the product of (i) the number of Class A Ordinary Shares actually sold in such rights offering (or
issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A Ordinary
Shares) and (ii) the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the fair market value.
For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A Ordinary Shares, in determining
the price payable for Class A Ordinary Shares, there will be taken into account any consideration received for such rights, as well as
any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of Class
A Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Class
A Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;In addition,
if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other
assets to all or substantially all the holders of Class A Ordinary Shares on account of such Class A Ordinary Shares (or other securities
into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends, (c) to satisfy the
redemption rights of the holders of Class A Ordinary Shares in connection with a proposed initial Business Combination, or (d) in connection
with the redemption of our public shares upon our failure to complete our initial Business Combination, then the warrant exercise price
will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of
any securities or other assets paid on each Class A ordinary share in respect of such event.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;If the number of outstanding
Class A Ordinary Shares is decreased by a consolidation, combination, reverse share subdivision or reclassification of Class A Ordinary
Shares or other similar event, then, on the effective date of such consolidation, combination, reverse share subdivision, reclassification
or similar event, the number of Class A Ordinary Shares issuable on exercise of each warrant will be decreased in proportion to such decrease
in outstanding Class A Ordinary Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Whenever the number of Class
A Ordinary Shares purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted
by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number
of Class A Ordinary Shares purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator
of which will be the number of Class A Ordinary Shares so purchasable immediately thereafter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in
connection with the closing of our initial Business Combination at a Newly Issued Price of less than $9.20 per Class A ordinary share,
(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds (including from such issuances
and this offering), and interest thereon, available for the funding of our initial Business Combination on the date of the consummation
of our initial Business Combination (net of redemptions), and (z) the Market Value of our Class A Ordinary Shares is below $&lt;span id="xdx_90F_ecustom--NewlyIssuedPrice_c20260101__20260331_z64npSdpVHe6" title="Newly issued price"&gt;9.20&lt;/span&gt; per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to &lt;span id="xdx_90D_ecustom--ClassOfWarrantsOrRightsExercisePricePercentage_iI_dp_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zMTJEbzkRxa8" title="Class of warrants or rights exercise price percentage"&gt;115&lt;/span&gt;% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described above under &#x201c;&lt;i&gt;Description of Securities - Warrants - Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00&lt;/i&gt;&#x201d; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;In case
of any reclassification or reorganization of the outstanding Class A Ordinary Shares (other than those described above or that solely
affects the par value of such Class A Ordinary Shares), or in the case of any merger or consolidation of us with or into another corporation
(other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of our issued and outstanding Class A Ordinary Shares), or in the case of any sale or conveyance to another corporation
or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which the Company is
dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and
conditions specified in the warrants and in lieu of the Class A Ordinary Shares immediately theretofore purchasable and receivable upon
the exercise of the rights represented thereby, the kind and amount of Class A Ordinary Shares or other securities or property (including
cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or
transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event
(the &#x201c;Alternative Issuance&#x201d;).&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The warrants will be issued
in registered form under a warrant agreement between Odyssey Transfer and Trust Company, as warrant agent, and us. The warrant agreement
provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or
to correct any defective provision or mistake, including to conform the provisions of the warrant agreement to the description of the
terms of the warrants and the warrant agreement set forth in this prospectus, (ii) adjusting the provisions relating to cash dividends
on Ordinary Shares as contemplated by and in accordance with the warrant agreement, (iii) adding or changing any provisions with respect
to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and
that the parties deem to not adversely affect the rights of the registered holders of the warrants or (iv) to provide for the delivery
of the Alternative Issuance. All other modifications or amendments require the vote or written consent of the holders of at least 50%
of the then-outstanding warrants. You can review a copy of the warrant agreement, which was filed as an exhibit to the registration statement
of which this prospectus is a part, for a complete description of the terms and conditions applicable to the warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The warrants may be exercised
upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form
on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price
(or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised.
The warrant holders do not have the rights or privileges of holders of Ordinary Shares and any voting rights until they exercise their
warrants and receive Class A Ordinary Shares. After the issuance of Class A Ordinary Shares upon exercise of the warrants, each holder
will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Share Rights&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;There were &lt;span id="xdx_909_ecustom--PublicShareRights_iI_c20260331_zFVPICAyhGK8" title="Public share rights"&gt;3,450,000&lt;/span&gt; Public Share Rights and &lt;span id="xdx_907_ecustom--PrivatePlacementShareRights_iI_c20260331_zvvtYJSPJNt1" title="Private placement share rights"&gt;55,893&lt;/span&gt; Private Placement Share Rights outstanding as of March 31, 2026. Except in cases where the Company is not the surviving company in a Business
Combination, each holder of a Share Right will automatically receive one-fifth (1/5) of one Class A ordinary share upon consummation of
the initial Business Combination, even if the holder of a Share Right redeemed all Class A Ordinary Shares held by it in connection with
the initial Business Combination or an amendment to the amended and restated memorandum and articles of association with respect to the
pre-Business Combination activities. In the event the Company will not be the surviving company upon completion of the initial Business
Combination, each holder of a Share Right will be required to affirmatively convert its Share Rights in order to receive the one-fifth
(1/5) of one Class A ordinary share underlying each Share Right upon consummation of the Business Combination. No additional consideration
will be required to be paid by a holder of Share Rights in order to receive its additional Class A Ordinary Shares upon consummation of
an initial Business Combination. The shares issuable upon exchange of the Share Rights will be freely tradable (except to the extent held
by affiliates of the Company).&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman Islands law. As a result, holders of Share Rights must hold Share Rights in multiples of 5 in order to receive shares for all of the Share Rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and it liquidates the funds held in the Trust Account, holders of Share Rights will not receive any of such funds with respect to their Share Rights, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with respect to such Share Rights, and the Share Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Share Rights upon consummation of an initial Business Combination. Additionally, in no event will the Company be required to net cash settle the Share Rights. Accordingly, the Share Rights may expire worthless.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Share Right agreement provides that, subject to applicable law, (i) any action, proceeding or claim against the Company arising out of or relating in any way to the Share Right agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that the Company irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. The Company will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. With respect to any complaint asserting a cause of action arising under the Securities Act or the rules and regulations promulgated thereunder, the Company notes, however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section&#160;22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;Notwithstanding
the foregoing, these provisions of the Share Right agreement will not apply to suits brought to enforce any liability or duty
created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole
and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of the Share Rights shall be deemed
to have notice of and to have consented to the forum provisions in the Share Right agreement. If any action, the subject matter of
which is within the scope of the forum provisions of the Share Right agreement, is filed in a court other than a court of the State
of New York or the United States District Court for the Southern District of New York (a &#x201c;foreign action&#x201d;) in the name
of any holder of the Share Rights, such holder shall be deemed to have consented to (x) the personal jurisdiction of the state and
federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum
provisions (an &#x201c;enforcement action&#x201d;); and (y) having service of process made upon such Share Right holder in any such
enforcement action by service upon such Share Right holder&#x2019;s counsel in the foreign action as agent for such Share Right
holder. This choice-of-forum provision may limit a Share Right holder&#x2019;s ability to bring a claim in a judicial forum that it
finds favorable for disputes with the Company, which may discourage such lawsuits. Alternatively, if a court were to find this
provision of the Share Right agreement inapplicable or unenforceable with respect to one or more of the specified types of actions
or proceedings, the Company may incur additional costs associated with resolving such matters in other jurisdictions, which could
materially and adversely affect its business, financial condition and results of operations and result in a diversion of the time
and resources of the management and board of directors.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000611"
      unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000613"
      unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000615"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000617"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000619"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000621"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000623"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000625"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000627"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000629"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000631"
      unitRef="Shares">1047994</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000633"
      unitRef="Shares">1047994</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000635"
      unitRef="Shares">1047994</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000637"
      unitRef="Shares">1047994</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000639"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000641"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000643"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000645"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-06-012025-06-28_custom_SponsorMember"
      decimals="0"
      id="Fact000647"
      unitRef="USD">5750000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <spacs:AggregatedPrice
      contextRef="From2025-06-012025-06-28_custom_FounderSharesMember"
      decimals="0"
      id="Fact000649"
      unitRef="USD">25000</spacs:AggregatedPrice>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000651"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000653"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000655"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000657"
      unitRef="Shares">5750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-03-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000665"
      unitRef="Shares">8625000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-03-31_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      id="Fact000667"
      unitRef="Shares">139733</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000669"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod
      contextRef="From2026-01-012026-03-31_custom_WarrantsMember"
      id="Fact000671">P30D</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod
      contextRef="From2026-01-012026-03-31_custom_WarrantsMember"
      id="Fact000672">P30D</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod>
    <spacs:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="From2026-01-012026-03-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact000680"
      unitRef="USDPShares">0.01</spacs:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <spacs:WarrantRedemptionConditionMinimumSharePrice
      contextRef="From2026-01-012026-03-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact000682"
      unitRef="USDPShares">18.00</spacs:WarrantRedemptionConditionMinimumSharePrice>
    <spacs:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="From2026-01-012026-03-31_custom_WarrantsMember"
      id="Fact000684">P20D</spacs:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <spacs:ThresholdConsecutiveTradingDaysForRedemptionOfWarrants
      contextRef="From2026-01-012026-03-31_custom_WarrantsMember"
      id="Fact000686">P30D</spacs:ThresholdConsecutiveTradingDaysForRedemptionOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000688"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <spacs:NewlyIssuedPrice
      contextRef="From2026-01-01to2026-03-31"
      decimals="INF"
      id="Fact000696"
      unitRef="USDPShares">9.20</spacs:NewlyIssuedPrice>
    <spacs:ClassOfWarrantsOrRightsExercisePricePercentage
      contextRef="AsOf2026-03-31_custom_WarrantsMember"
      decimals="INF"
      id="Fact000698"
      unitRef="Ratio">1.15</spacs:ClassOfWarrantsOrRightsExercisePricePercentage>
    <spacs:PublicShareRights
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000706"
      unitRef="Shares">3450000</spacs:PublicShareRights>
    <spacs:PrivatePlacementShareRights
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000708"
      unitRef="Shares">55893</spacs:PrivatePlacementShareRights>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000716">&lt;p id="xdx_808_eus-gaap--FairValueDisclosuresTextBlock_zXzoQebn2jwh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 8 &#x2014; &lt;span id="xdx_822_zOnJUdLIOcK5"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 0.5in; text-align: justify"&gt;Level 1:&lt;/td&gt;
&lt;td style="text-align: justify"&gt;Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 0.5in; text-align: justify"&gt;Level 2:&lt;/td&gt;
&lt;td style="text-align: justify"&gt;Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;Level 3:&lt;/td&gt;
&lt;td style="text-align: justify"&gt;Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value as of March&#160;31, 2026 and December&#160;31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zcrmymRSyLI3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B8_zZrn8RqXQWGi" style="display: none"&gt;Schedule of  fair value, assets measured on recurring basis&lt;/span&gt; &lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level&lt;/b&gt;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;March&#160;31,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Assets:&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Cash and marketable securities held in Trust Account&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: center; vertical-align: bottom"&gt;1&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20260331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0hXXRB9Aho" style="text-align: right" title="Cash and marketable securities held in Trust Account"&gt;173,360,706&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20251231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgT3wdCxxBYj" style="text-align: right" title="Cash and marketable securities held in Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;-&lt;/span&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A9_z4CdLRtXPjT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The fair value of the Public Warrants is $&lt;span id="xdx_90F_ecustom--FairValueOfPublicWarrants_iI_c20260209_zdu53PyUnu2f" title="Fair value of public warrants"&gt;974,625&lt;/span&gt;, or approximately $0.11 per Public Warrant. The fair value of Public Warrants was determined using Monte Carlo Simulation Model. The Public Warrants have been classified within shareholders&#x2019; deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Public Warrants:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zY0M8U143UI2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 1)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zv0Rk7Qon2U7" style="display: none"&gt;Schedule of fair value of the Public Warrants&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;February&#160;9,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Underlying stock price&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zCote31m2BLk" style="width: 9%; text-align: right" title="Underlying stock price"&gt;9.72&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Exercise price&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z4RrPGoado6a" style="text-align: right" title="Exercise price"&gt;11.50&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Remaining term (years)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zh3vv3QhJNh2" title="Remaining Term (years)"&gt;6.24&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Volatility&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zQajYBivdnF6" title="Volatility"&gt;5.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Risk-free rate&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zYXj8nHK7cJ7" title="Risk-free rate"&gt;3.81&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Pre-adjusted value per share&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--PreadjustedValuePerShare_iI_dtY_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zkV3Y750jNme" title="Pre-Adjusted Value per Share"&gt;0.86&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Market adjustment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--MarketAdjustment_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zVoYX270rEP2" title="Market Adjustment"&gt;13.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A0_zRf3yidkm3z7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The fair value of the Public Rights is $&lt;span id="xdx_90C_ecustom--FairValueOfPublicRights_iI_c20260209_ze6bMsQLdsm6" title="Fair value of public rights"&gt;4,398,750&lt;/span&gt;, or approximately $0.26 per Public Right. The fair value of Public Rights was determined using Monte Carlo Simulation Model. The Public Rights have been classified within shareholders&#x2019; deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Public Rights:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfMarketAssumptionsUsedInTheValuationOfThePublicRightsTableTextBlock_zuurKtHa6Ck7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 2)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zGnls2DznHpf" style="display: none"&gt;Schedule of fair value of public rights&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;February&#160;9,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Underlying stock price&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicRightsMember_zw1brsByBgVl" style="width: 9%; text-align: right" title="Underlying stock price"&gt;9.72&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Pre-adjusted value per share&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--PreadjustedValuePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicRightsMember_zcoF75vjb2T7" title="Pre-Adjusted Value per Share"&gt;1.94&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Market adjustment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MarketAdjustment_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicRightsMember_zJmGdnCeN9ca" title="Market Adjustment"&gt;13.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A6_zDHeTKamSKng" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The fair value of the Restricted Shares is $&lt;span id="xdx_909_ecustom--FairValueOfRestrictedShares_iI_c20260209_zRHTR4Xooeal" title="Fair value of restricted shares"&gt;981,412&lt;/span&gt;, or approximately $1.28 per Restricted Share. The fair value of Restricted Shares was determined using Monte Carlo Simulation Model. The Restricted Shares have been classified within shareholders&#x2019; deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Restricted Shares:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfMarketAssumptionsUsedInTheValuationOfTheRestrictedSharesTableTextBlock_zKFNwMDnYHK4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 3)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_zwZepWr6mXhg" style="display: none"&gt;Schedule of fair value of restricted shares&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;February&#160;9,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Underlying stock price&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--RestrictedSharesMember_zi0L4BFwp7h7" style="width: 9%; text-align: right" title="Underlying stock price"&gt;9.72&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Pre-adjusted value per share&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--PreadjustedValuePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--RestrictedSharesMember_zWWwIvhCdW2d" title="Pre-Adjusted Value per Share"&gt;9.72&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Market adjustment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--MarketAdjustment_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--RestrictedSharesMember_znU9FLYYGUkh" title="Market Adjustment"&gt;13.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A9_zqYw2PG0Skyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;













</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000724">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zcrmymRSyLI3" style="font: 10pt Times New Roman; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;&lt;span id="xdx_8B8_zZrn8RqXQWGi" style="display: none"&gt;Schedule of  fair value, assets measured on recurring basis&lt;/span&gt; &lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level&lt;/b&gt;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;March&#160;31,&lt;br/&gt;2026&lt;/b&gt;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;th colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/th&gt;
&lt;th style="padding-bottom: 0.5pt"&gt;&#160;&lt;/th&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Assets:&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top"&gt;Cash and marketable securities held in Trust Account&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: center; vertical-align: bottom"&gt;1&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20260331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0hXXRB9Aho" style="text-align: right" title="Cash and marketable securities held in Trust Account"&gt;173,360,706&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20251231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgT3wdCxxBYj" style="text-align: right" title="Cash and marketable securities held in Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;-&lt;/span&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000726"
      unitRef="USD">173360706</us-gaap:AssetsHeldInTrustNoncurrent>
    <spacs:FairValueOfPublicWarrants
      contextRef="AsOf2026-02-09"
      decimals="0"
      id="Fact000730"
      unitRef="USD">974625</spacs:FairValueOfPublicWarrants>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000732">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zY0M8U143UI2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 1)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BD_zv0Rk7Qon2U7" style="display: none"&gt;Schedule of fair value of the Public Warrants&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;February&#160;9,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Underlying stock price&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zCote31m2BLk" style="width: 9%; text-align: right" title="Underlying stock price"&gt;9.72&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Exercise price&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z4RrPGoado6a" style="text-align: right" title="Exercise price"&gt;11.50&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Remaining term (years)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zh3vv3QhJNh2" title="Remaining Term (years)"&gt;6.24&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Volatility&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zQajYBivdnF6" title="Volatility"&gt;5.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Risk-free rate&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zYXj8nHK7cJ7" title="Risk-free rate"&gt;3.81&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Pre-adjusted value per share&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--PreadjustedValuePerShare_iI_dtY_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zkV3Y750jNme" title="Pre-Adjusted Value per Share"&gt;0.86&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Market adjustment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--MarketAdjustment_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_zVoYX270rEP2" title="Market Adjustment"&gt;13.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
      contextRef="AsOf2026-02-09_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000734"
      unitRef="USDPShares">9.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-02-09_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000736"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2026-02-012026-02-09_custom_PublicWarrantsMember"
      id="Fact000738">P6Y2M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2026-02-012026-02-09_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000740"
      unitRef="Ratio">0.050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2026-02-012026-02-09_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000742"
      unitRef="Ratio">0.0381</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <spacs:PreadjustedValuePerShare
      contextRef="AsOf2026-02-09_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000744"
      unitRef="USDPShares">0.86</spacs:PreadjustedValuePerShare>
    <spacs:MarketAdjustment
      contextRef="From2026-02-012026-02-09_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact000746"
      unitRef="Ratio">0.131</spacs:MarketAdjustment>
    <spacs:FairValueOfPublicRights
      contextRef="AsOf2026-02-09"
      decimals="0"
      id="Fact000748"
      unitRef="USD">4398750</spacs:FairValueOfPublicRights>
    <spacs:ScheduleOfMarketAssumptionsUsedInTheValuationOfThePublicRightsTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000750">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfMarketAssumptionsUsedInTheValuationOfThePublicRightsTableTextBlock_zuurKtHa6Ck7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 2)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8BA_zGnls2DznHpf" style="display: none"&gt;Schedule of fair value of public rights&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;February&#160;9,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Underlying stock price&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicRightsMember_zw1brsByBgVl" style="width: 9%; text-align: right" title="Underlying stock price"&gt;9.72&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Pre-adjusted value per share&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--PreadjustedValuePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicRightsMember_zcoF75vjb2T7" title="Pre-Adjusted Value per Share"&gt;1.94&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Market adjustment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--MarketAdjustment_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicRightsMember_zJmGdnCeN9ca" title="Market Adjustment"&gt;13.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</spacs:ScheduleOfMarketAssumptionsUsedInTheValuationOfThePublicRightsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
      contextRef="AsOf2026-02-09_custom_PublicRightsMember"
      decimals="INF"
      id="Fact000752"
      unitRef="USDPShares">9.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
    <spacs:PreadjustedValuePerShare
      contextRef="AsOf2026-02-09_custom_PublicRightsMember"
      decimals="INF"
      id="Fact000754"
      unitRef="USDPShares">1.94</spacs:PreadjustedValuePerShare>
    <spacs:MarketAdjustment
      contextRef="From2026-02-012026-02-09_custom_PublicRightsMember"
      decimals="INF"
      id="Fact000756"
      unitRef="Ratio">0.131</spacs:MarketAdjustment>
    <spacs:FairValueOfRestrictedShares
      contextRef="AsOf2026-02-09"
      decimals="0"
      id="Fact000758"
      unitRef="USD">981412</spacs:FairValueOfRestrictedShares>
    <spacs:ScheduleOfMarketAssumptionsUsedInTheValuationOfTheRestrictedSharesTableTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000760">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfMarketAssumptionsUsedInTheValuationOfTheRestrictedSharesTableTextBlock_zKFNwMDnYHK4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 3)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B1_zwZepWr6mXhg" style="display: none"&gt;Schedule of fair value of restricted shares&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;February&#160;9,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Underlying stock price&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--RestrictedSharesMember_zi0L4BFwp7h7" style="width: 9%; text-align: right" title="Underlying stock price"&gt;9.72&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Pre-adjusted value per share&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--PreadjustedValuePerShare_iI_c20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--RestrictedSharesMember_zWWwIvhCdW2d" title="Pre-Adjusted Value per Share"&gt;9.72&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Market adjustment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--MarketAdjustment_dp_c20260201__20260209__us-gaap--SubsidiarySaleOfStockAxis__custom--RestrictedSharesMember_znU9FLYYGUkh" title="Market Adjustment"&gt;13.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</spacs:ScheduleOfMarketAssumptionsUsedInTheValuationOfTheRestrictedSharesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
      contextRef="AsOf2026-02-09_custom_RestrictedSharesMember"
      decimals="INF"
      id="Fact000762"
      unitRef="USDPShares">9.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
    <spacs:PreadjustedValuePerShare
      contextRef="AsOf2026-02-09_custom_RestrictedSharesMember"
      decimals="INF"
      id="Fact000764"
      unitRef="USDPShares">9.72</spacs:PreadjustedValuePerShare>
    <spacs:MarketAdjustment
      contextRef="From2026-02-012026-02-09_custom_RestrictedSharesMember"
      decimals="INF"
      id="Fact000766"
      unitRef="Ratio">0.131</spacs:MarketAdjustment>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000774">&lt;p id="xdx_804_eus-gaap--SegmentReportingDisclosureTextBlock_zwzWRCC0WO7g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 9 &#x2014; &lt;span id="xdx_828_zGTlQlTEtm4e"&gt;Segment Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;i&gt;Segment Information&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;ASC Topic 280, &#x201c;Segment
Reporting,&#x201d; establishes standards for companies to report in their financial statements information about operating segments, products,
services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business
activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is
regularly evaluated by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), or group, in deciding how to allocate
resources and assess performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company&#x2019;s CODM
has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics for the Company as
a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that
the Company only has one reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The CODM
assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on
the unaudited condensed statement of operations as net income or loss. The measure of segment assets is reported on the condensed balance
sheets as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM
reviews several key metrics, which include the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zQvixD3oiNA1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zRBv3mgzzhsi" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49C_20260331_zSiDy4nw7aTl" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20251231_zrxXRQiWksv2" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;March&#160;31,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CashEquivalentsAtCarryingValue_iI_zCJ4WcEIBWg9" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash equivalents&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;308,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;6,081&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AssetsHeldInTrust_iI_zkTh67tfk271" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and investments held in Trust Account&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;173,360,706&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" id="xdx_498_20260101__20260331_zI7oHREkarg5" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt;Three Months Ended&lt;br/&gt;March&#160;31,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_z5WJOlqUr3y4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;General and administrative expenses&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;212,358&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AB_zDNfImtMMh1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;General and administrative
expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business
Combination or similar transaction within the Business Combination period. The CODM also reviews general and administrative expenses to
manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative
expenses, as reported on the unaudited condensed statements of operations, are the significant segment expenses provided to the CODM on
a regular basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;
</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000776">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zQvixD3oiNA1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span id="xdx_8B6_zRBv3mgzzhsi" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49C_20260331_zSiDy4nw7aTl" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20251231_zrxXRQiWksv2" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;March&#160;31,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt;2025&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CashEquivalentsAtCarryingValue_iI_zCJ4WcEIBWg9" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash equivalents&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;308,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;6,081&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AssetsHeldInTrust_iI_zkTh67tfk271" style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and investments held in Trust Account&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;173,360,706&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" id="xdx_498_20260101__20260331_zI7oHREkarg5" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #FFFFFF; vertical-align: bottom"&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt;Three Months Ended&lt;br/&gt;March&#160;31,&lt;br/&gt;2026&lt;/b&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_z5WJOlqUr3y4" style="background-color: #CCEEFF; vertical-align: bottom"&gt;
&lt;td style="text-align: left; vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"&gt;General and administrative expenses&lt;/td&gt;
&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; text-align: right"&gt;212,358&lt;/td&gt;
&lt;td style="width: 1%; text-align: left; white-space: nowrap"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000778"
      unitRef="USD">308000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000779"
      unitRef="USD">6081</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AssetsHeldInTrust
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000781"
      unitRef="USD">173360706</us-gaap:AssetsHeldInTrust>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-03-31"
      decimals="0"
      id="Fact000784"
      unitRef="USD">212358</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2026-01-01to2026-03-31" id="Fact000786">&lt;p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zoBMPGVIAsd1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Note 10 &#x2014; &lt;span id="xdx_820_zi1KTmQ3HHVd"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0; margin-bottom: 0"&gt;The Company
evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet dated March&#160;31, 2026, through
the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent
events that would have required adjustment or disclosure in the unaudited condensed financial statements.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2026-01-01to2026-03-31" id="Fact000787">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2026-01-01to2026-03-31" id="Fact000788">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2026-01-01to2026-03-31" id="Fact000789">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2026-01-01to2026-03-31" id="Fact000790">false</ecd:Rule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000167"
          xlink:label="Fact000167"
          xlink:type="locator"/>
        <link:footnote id="Footnote000190" xlink:label="Footnote000190" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number includes an aggregate of up to 750,000 Class B Ordinary Shares that were subject to forfeiture if the over-allotment option had not been exercised in full or in part by the underwriters. On February&#160;9, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering (as defined in Note 1). As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, those 750,000 Founder Shares are no longer subject to forfeiture by the Sponsor (Note 4).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000167"
          xlink:to="Footnote000190"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000169"
          xlink:label="Fact000169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000169"
          xlink:to="Footnote000190"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000171"
          xlink:label="Fact000171"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000171"
          xlink:to="Footnote000190"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000173"
          xlink:label="Fact000173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000173"
          xlink:to="Footnote000190"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000175"
          xlink:label="Fact000175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000175"
          xlink:to="Footnote000190"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000177"
          xlink:label="Fact000177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000177"
          xlink:to="Footnote000190"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000210"
          xlink:label="Fact000210"
          xlink:type="locator"/>
        <link:footnote id="Footnote000217" xlink:label="Footnote000217" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number includes an aggregate of up to 750,000 Class B Ordinary Shares that were subject to forfeiture if the over-allotment option had not been exercised in full or in part by the underwriters. On February&#160;9, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, those 750,000 Founder Shares are no longer subject to forfeiture by the Sponsor (Note 4).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000210"
          xlink:to="Footnote000217"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000214"
          xlink:label="Fact000214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000214"
          xlink:to="Footnote000217"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
